ReviewClinical and experimental vaccine research2022
SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants.
Rike Syahniar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it